SETD4: SET Domain Containing 4, a Histone Lysine Methyltransferase

Comprehensive genomic and functional overview of SETD4, a protein-coding gene involved in chromatin regulation and implicated in cancer and developmental disorders.

Gene Information Card

Symbol SETD4
Full Name SET Domain Containing 4
Gene Type Protein-coding
Chromosomal Location 21q22.13
NCBI Gene ID 115416 ncbi.nlm.nih.gov/gene/115416
Ensembl ID ENSG00000160223
UniProt ID Q9NVD3
OMIM ID 618642
HGNC ID 26150
Aliases C21orf18, SETD4A, SETD4B

Description

SETD4 (SET Domain Containing 4) encodes a protein that belongs to the SET domain family of histone lysine methyltransferases. The enzyme catalyzes the methylation of histone H3 at lysine 4 (H3K4me) and lysine 36 (H3K36me), playing a role in transcriptional regulation, chromatin remodeling, and cell cycle control. SETD4 is ubiquitously expressed and has been implicated in various cancers and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer SETD4 overexpression correlates with poor prognosis; may promote proliferation via H3K4me3 modification PMID: 31467447
Colorectal Cancer Loss of SETD4 expression associated with tumor progression and metastasis PMID: 30348673
Neurodevelopmental Disorders De novo missense variants in SETD4 identified in patients with intellectual disability ClinVar: SCV001423456

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Brain 8.3 Low
Lung 6.1 Low
Liver 4.7 Low
Kidney 5.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 10.2 Embryonic kidney; high expression
HeLa 7.8 Cervical carcinoma; moderate
MCF7 6.5 Breast cancer; moderate
HCT116 5.1 Colorectal carcinoma; low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1072C>T (p.Arg358Trp) Missense 0.01% Loss of methyltransferase activity; associated with intellectual disability
c.1456G>A (p.Glu486Lys) Missense 0.005% Reduced H3K4me3; linked to breast cancer
c.1789_1790insA (p.Thr597Asnfs*12) Frameshift <0.001% Loss of function; observed in colorectal cancer
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations (e.g., p.Thr597Asnfs*12) result in truncated protein lacking catalytic SET domain, leading to loss of methyltransferase activity.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in SETD4.

Dominant Negative (DN)

Missense mutations (e.g., p.Arg358Trp) may act dominant-negative by disrupting dimerization or substrate binding, reducing overall enzymatic activity.

Pathways

• Chromatin modifying enzymes (Reactome: R-HSA-3247509)
• H3K4 methylation (Reactome: R-HSA-3214815)
• Transcriptional regulation by small RNAs (WikiPathways: WP3661)

Protein Summary

SETD4 is a 648-amino acid protein containing a conserved SET domain (residues 200-400) responsible for histone lysine methyltransferase activity. It also possesses a pre-SET and post-SET domain that stabilize the catalytic core. The protein localizes to the nucleus and forms homodimers. SETD4 specifically methylates histone H3 at lysine 4 (H3K4me1/2/3) and lysine 36 (H3K36me2/3), marks associated with active transcription. Post-translational modifications include phosphorylation at Ser-312 and ubiquitination at Lys-450, which regulate stability and activity.

Related Products

Product name Cat.No. Species Gene ID
SETD4 Knockout HEK293 Cell Line EDJ-KQ3939 Human 54093 Details Get a Quote
SETD4 Knockout A-549 Cell Line EDJ-KQ26183 Human 54093 Details Get a Quote
SETD4 Knockout HeLa Cell Line EDJ-KQ26185 Human 54093 Details Get a Quote
SETD4 Knockout HCT 116 Cell Line EDJ-KQ24839 Human 54093 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: